Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

Stephen J. Ubl to Lead PhRMA as Next President and CEO

September 25, 2015

Stephen J. Ubl joins PhRMA after more than ten years as the president and CEO of AdvaMed, the world’s largest medical technology association.

Read More

PhRMA: Clinton Propuesta revertiría la innovación médica

September 22, 2015

PhRMA emitió a declaración en respuesta a la propuesta lanzada por la Secretaria Clinton para regular los precios de medicamentos con receta.

Read More

836 Medicines and Vaccines in Development to Treat Cancer

September 9, 2015

America’s biopharmaceutical research companies are currently working to develop 836 medicines and vaccines to treat a broad range of cancers.

Read More

PhRMA Honors 2015 Research & Hope Award Recipients

September 9, 2015

PhRMA honors researchers and patient advocates for their roles in advancing innovative biopharmaceutical research and improving patient care.

Read More

PhRMA Lanza Nuevos Recursos del Cuidado de la Salud

August 31, 2015

PhRMA lanzaron AccessBetterCoverage.com/espanol, un centro de recursos sobre la atención de la salud, el seguro y consejos para la compra de cobertura de salud.

Read More

PhRMA Launches New Spanish-Language Health Care Resources

August 31, 2015

PhRMA launched Access BetterCoverage.org/espanol, a hub of Spanish-language resources on health care, health insurance and tips for shopping for coverage.

Read More

More Than 400 New Medicines for Neurological Disorders

July 13, 2015

America’s biopharmaceutical research companies are currently developing 420 medicines for patients suffering from neurological disorders, including epilepsy, Alzheimer’s disease, multiple sclerosis (MS) and Parkinson’s disease.

Read More